JOSHUA HILTON: Open Payments
NPI 1639822257 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 66 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $393 · 2025 $1,729
Food & beverage: $1,729
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $425 |
| ABBVIE INC. | 11 | $312 |
| Vanda Pharmaceuticals Inc. | 7 | $275 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Corium, LLC | 4 | $87 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Noven Therapeutics, LLC | 2 | $39 |
Products named: COBENFY, VRAYLAR, FANAPT, Auvelity, CAPLYTA, Azstarys, REXULTI, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
